Healthcare -
Drug Manufacturers - General - NYSE - US
$ 171.56
-1.23 %
$ 303 B
Market Cap
59.99
P/E
ABBV - STOCK-BASED COMPENSATION
Stock-based Compensation ABBV - AbbVie Inc.
747 M
LAST VALUE
3.90%
2 YEAR CAGR
12.15%
5 YEAR CAGR
13.42%
10 YEAR CAGR